Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $355.81 | 11 | 96.9% |
| Education | $11.38 | 1 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $189.22 | 5 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $90.59 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $43.71 | 3 | $0 (2019) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $23.35 | 1 | $0 (2018) |
| AbbVie Inc. | $14.28 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $14.28 | 1 | AbbVie Inc. ($14.28) |
| 2019 | $143.94 | 3 | Otsuka America Pharmaceutical, Inc. ($125.00) |
| 2018 | $197.59 | 7 | Teva Pharmaceuticals USA, Inc. ($90.59) |
| 2017 | $11.38 | 1 | Otsuka America Pharmaceutical, Inc. ($11.38) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/06/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2019 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 07/24/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Neuroscience | ||||||
| 05/19/2019 | Otsuka America Pharmaceutical, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 08/22/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: PSYCHIATRY | ||||||
| 08/10/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Neuroscience | ||||||
| 07/19/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $90.59 | General |
| Category: Central Nervous System | ||||||
| 07/10/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Neuroscience | ||||||
| 05/03/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: PSYCHIATRY | ||||||
| 03/22/2018 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $23.35 | General |
| 03/08/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: PSYCHIATRY | ||||||
| 07/19/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Education | In-kind items and services | $11.38 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 103 | 165 | $17,347 | $9,130 |
| 2022 | 4 | 144 | 297 | $31,892 | $19,032 |
| 2021 | 3 | 169 | 368 | $50,704 | $23,921 |
| 2020 | 4 | 120 | 281 | $66,093 | $20,003 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 42 | 83 | $10,043 | $5,156 | 51.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2023 | 31 | 46 | $3,496 | $1,938 | 55.4% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Facility | 2023 | 19 | 25 | $2,400 | $1,298 | 54.1% |
| 90838 | Psychotherapy with evaluation and management visit, 1 hour | Facility | 2023 | 11 | 11 | $1,408 | $737.73 | 52.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 52 | 149 | $18,029 | $10,367 | 57.5% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Facility | 2022 | 32 | 52 | $4,992 | $3,222 | 64.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2022 | 39 | 68 | $5,287 | $3,096 | 58.6% |
| 90838 | Psychotherapy with evaluation and management visit, 1 hour | Facility | 2022 | 21 | 28 | $3,584 | $2,347 | 65.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 49 | 146 | $18,565 | $11,300 | 60.9% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Facility | 2021 | 43 | 106 | $8,781 | $5,384 | 61.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 48 | $13,632 | $3,698 | 27.1% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Facility | 2021 | 22 | 32 | $3,066 | $2,055 | 67.0% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 24 | 36 | $6,660 | $1,485 | 22.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 44 | 140 | $39,373 | $11,120 | 28.2% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 37 | 81 | $14,743 | $4,508 | 30.6% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 26 | 45 | $10,306 | $3,179 | 30.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 15 | $1,671 | $1,196 | 71.6% |
About Dr. Miles Ardaman, M.D
Dr. Miles Ardaman, M.D is a Psychiatry healthcare provider based in Thief River Falls, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831142702.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Miles Ardaman, M.D has received a total of $367.19 in payments from pharmaceutical and medical device companies, with $14.28 received in 2021. These payments were reported across 12 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($355.81).
As a Medicare-enrolled provider, Ardaman has provided services to 536 Medicare beneficiaries, totaling 1,111 services with total Medicare billing of $72,086. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry, Psychiatry
- Location Thief River Falls, MN
- Active Since 05/19/2006
- Last Updated 06/18/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1831142702
Products in Payments
- AUSTEDO (Drug) $90.59
- ABILIFY MAINTENA (Drug) $64.22
- INVEGA SUSTENNA (Drug) $30.81
- VRAYLAR (Drug) $14.28
- SPRAVATO (Drug) $12.90
- NEUROSTAR TMS THERAPY (Device) $6.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.